<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03416413</url>
  </required_header>
  <id_info>
    <org_study_id>17/WS/0192</org_study_id>
    <nct_id>NCT03416413</nct_id>
  </id_info>
  <brief_title>Study of Foam Sclerotherapy Versus Ambulatory Phlebectomy</brief_title>
  <official_title>Randomised Controlled Trial of Foam Sclerotherapy Versus Ambulatory Phlebectomy for the Treatment of Varicose Vein Tributaries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be comparing the treatment of varicose vein tributaries using either foam
      sclerotherapy or ambulatory phlebectomies. Patients will be randomised to having either
      ambulatory phlebectomy (group A) or foam sclerotherapy (group B) following treatment of their
      saphenous vein.

      The re-intervention rates, safety, patient experience as well as the cost effectiveness of
      each intervention will be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Re-intervention rate</measure>
    <time_frame>12 months</time_frame>
    <description>Re-intervention on varicose vein tributaries during study period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Generic quality of life score</measure>
    <time_frame>12 months</time_frame>
    <description>Quality of life score using the EuroQol's EQ-5D [0=worse quality of life; 1=best quality of life]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-specific quality of life score</measure>
    <time_frame>12 months</time_frame>
    <description>Quality of life score using the Aberdeen Varicose Vein Questionnaire (AVVQ) [0=worse quality of life; 100= best quality of life]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease specific quality of life score</measure>
    <time_frame>12 months</time_frame>
    <description>Quality of life score using the ChronIc Venous Insufficiency Quality of Life Questionnaire (CIVIQ) [0=worse quality of life; 100=best quality of life]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical score</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical change using the Venous Clinical Severity Score (VCSS) [0=least severe disease; 30=most severe disease]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical score</measure>
    <time_frame>12 months</time_frame>
    <description>Using the Clinical-Etiological-Anatomical-Pathophysiological (CEAP) classification [0=no varicose veins; 1=telangiectasia; 2= varicose veins; 3=oedema; 4=skin changes; 5=healed ulcer; 6=ulcer]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score over the first 10 days</measure>
    <time_frame>2 weeks</time_frame>
    <description>Pain score over the first 10 days using a 0-100mm visual analogue scale (0=no pain; 100=worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of bruising at 2 weeks</measure>
    <time_frame>2 weeks</time_frame>
    <description>Degree of bruising at 2 weeks using a categorical 0-5 bruising scale (0=no bruising; 5=bruising extending beyond treated segment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to return to normal activities</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>Ambulatory Phlebectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ambulatory phlebectomy of varicose vein tributaries</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Foam Sclerotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection of foam sclerosant into varicose vein tributaries</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ambulatory phlebectomy</intervention_name>
    <description>Minor surgery to remove varicose vein tributaries</description>
    <arm_group_label>Ambulatory Phlebectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Foam sclerotherapy</intervention_name>
    <description>Injection of foam sclerosant into varicose vein tributaries</description>
    <arm_group_label>Foam Sclerotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults over 18 years of age

          -  Symptomatic GSV or SSV vein reflux &gt; 0.5 seconds on colour Duplex

          -  Varicose vein tributary requiring treatment

        Exclusion Criteria:

          -  Current DVT

          -  Recurrent varicose veins

          -  Arterial disease (ABPI&lt;0.8)

          -  Vein diameter &lt; 3mm

          -  Preference for one of the treatment options

          -  Patient who are unwilling to participate

          -  Inability or unwillingness to complete questionnaires

          -  Inability to attend follow-up appointments

          -  Patient currently included in a study of varicose vein treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amjad Belramman</last_name>
    <phone>02033117335</phone>
    <email>a.belramman17@imperial.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roshan Bootun</last_name>
    <phone>02033117335</phone>
    <email>r.bootun@imperial.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charing Cross Hospital, Imperial College London</name>
      <address>
        <city>London</city>
        <zip>W6 8RF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amjad Belramman</last_name>
      <phone>+442033117335</phone>
      <email>a.belramman17@imperial.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Roshan Bootun</last_name>
      <phone>+442033117335</phone>
      <email>r.bootun@imperial.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Alun H Davies</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tristan RA Lane</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roshan Bootun</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amjad Belramman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>January 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <last_update_submitted>March 12, 2018</last_update_submitted>
  <last_update_submitted_qc>March 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

